Cancer Discov. 2020 May;10(5):OF3. doi: 10.1158/2159-8290.CD-NB2020-018. Epub 2020 Mar 24.
As COVID-19 continues to surge, cancer scientists engaged in basic research face unique challenges. At centers throughout the United States, investigators are confronting difficult decisions about which experiments to continue, while securing supplies and creating contingency plans for a complete shutdown.
随着 COVID-19 的持续蔓延，从事基础研究的癌症科学家面临着独特的挑战。在美国各地的研究中心，研究人员正在艰难地决定继续进行哪些实验，同时确保供应品的安全，并为全面关闭制定应急计划。
